P2.07. Factors Associated with Disease Progression after Discontinuation of Immunotherapy for Immune-Related Toxicity in Non-small Cell Lung Cancer - PDF(Abstract)
Back to course
Pdf Summary
Asset Subtitle
Biagio Ricciuti
Meta Tag
Speaker Biagio Ricciuti
Topic Metastatic NSCLC: Immunotherapy - Retrospective
WCLC 2023 conference
disease progression
immune-related toxicity
non-small cell lung cancer
NSCLC patients
progression-free survival
overall survival
PD-L1 levels
Powered By